|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/22/2024 |
$4.91 |
$5.95 |
$4.91 |
$5.45 |
197.90K | 04/23/2024 |
$5.38 |
$5.90 |
$5.00 |
$5.68 |
82.00K | 04/24/2024 |
$5.15 |
$5.31 |
$4.83 |
$5.16 |
51.30K | 04/25/2024 |
$5.05 |
$5.24 |
$5.05 |
$5.07 |
12.50K | 04/26/2024 |
$5.04 |
$5.51 |
$5.04 |
$5.23 |
28.50K |
|
Windtree Therapeutics is a biopharmaceutical company focused on the development of therapeutics. Co.'s primary product candidate, istaroxime, is a dual-acting agent being developed to improve cardiac function in patients with acute heart failure. Co.'s heart failure cardiovascular portfolio also includes sarco endoplasmic reticulum Ca2+ -ATPase 2a (SERCA2a) activators. This research program is evaluating these preclinical product candidates, including oral and intravenous SERCA2a activator heart failure compounds. In addition, Co.'s cardiovascular drug product candidates include rostafuroxin, a product candidate for the treatment of hypertension in patients with a specific genetic profile. | |
|
Windtree Therapeutics (WINT) has the following price history information. Looking back at WINT historical stock prices for the last five trading days, on April 22, 2024, WINT opened at $4.91, traded as high as $5.95 and as low as $4.91, and closed at $5.45. Trading volume was a total of 197.90K shares. On April 23, 2024, WINT opened at $5.38, traded as high as $5.90 and as low as $5.00, and closed at $5.68. Trading volume was a total of 82.00K shares. On April 24, 2024, WINT opened at $5.15, traded as high as $5.31 and as low as $4.83, and closed at $5.16. Trading volume was a total of 51.30K shares. On April 25, 2024, WINT opened at $5.05, traded as high as $5.24 and as low as $5.05, and closed at $5.07. Trading volume was a total of 12.50K shares. On April 26, 2024, WINT opened at $5.04, traded as high as $5.51 and as low as $5.04, and closed at $5.23. Trading volume was a total of 28.50K shares.
WINT Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Windtree Therapeutics shares, starting with a $10,000 purchase of WINT, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/29/2014 |
|
End date: |
04/26/2024 |
|
Start price/share: |
$1,584.00 |
|
End price/share: |
$5.23 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.67% |
|
Average Annual Total Return: |
-43.52% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$33.03 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
04/22/2024 | $5.45 | 04/23/2024 | $5.68 | 04/24/2024 | $5.16 | 04/25/2024 | $5.07 | 04/26/2024 | $5.23 |
|
|